Cargando…
Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening
BACKGROUND: Our objective was to analyse the cost effectiveness of computed tomography (CT) screening for lung cancer in terms of the cost per long-term survivor, which has not been evaluated to date. METHODS: Estimations were computed based on data from the Surveillance, Epidemiology, and End Resul...
Autores principales: | Castleberry, A W, Smith, D, Anderson, C, Rotter, A J, Grannis, F W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743357/ https://www.ncbi.nlm.nih.gov/pubmed/19690541 http://dx.doi.org/10.1038/sj.bjc.6605253 |
Ejemplares similares
-
What is a reasonable cost to refute a preposterous hypothesis?
por: Castleberry, A W, et al.
Publicado: (2010) -
Are We Underestimating Efficacy and Cost-Efficacy of Population Lung Cancer Computed Tomography Screening?
por: Grannis, Frederic W.
Publicado: (2022) -
Computed tomography scan imaging in diagnosing acute uncomplicated pancreatitis: Usefulness vs cost
por: Kothari, Shana, et al.
Publicado: (2019) -
Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?
por: Wishart, G C, et al.
Publicado: (2008) -
Incidental vs symptomatic renal tumours: Survival outcomes
por: Al-Marhoon, Mohammed S., et al.
Publicado: (2011)